Skip to main content

Peer Review reports

From: Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer

Original Submission
10 Apr 2017 Submitted Original manuscript
3 Jul 2017 Reviewed Reviewer Report - Fátima Baltazar
17 Jul 2017 Reviewed Reviewer Report - Yong Li
18 Aug 2017 Author responded Author comments - Masayuki Hagiwara
Resubmission - Version 2
18 Aug 2017 Submitted Manuscript version 2
9 Sep 2017 Reviewed Reviewer Report - Fátima Baltazar
25 Oct 2017 Author responded Author comments - Masayuki Hagiwara
Resubmission - Version 3
25 Oct 2017 Submitted Manuscript version 3
Publishing
14 Jan 2018 Editorially accepted
31 Jan 2018 Article published 10.1186/s12885-018-3988-3

You can find further information about peer review here.

Back to article page